Ultraprocessed food (UPF), health, and mechanistic uncertainty: What should we be advising the public to do about UPFs?

IF 15.8 1区医学 Q1 Medicine

PLoS Medicine Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI:10.1371/journal.pmed.1004439

Eric Robinson, Alexandra M Johnstone

引用次数: 0

Abstract

In this perspective, we discuss why current mechanistic uncertainty on ultraprocessed foods (UPFs) and health acts as a major challenge to providing informed dietary guidelines and public advice on UPFs. Based on the balance of current evidence, we do not believe it is appropriate to be advising consumers to avoid all UPFs and we await further evidence to inform consumer guidance on the need to limit consumption of specifics foods based on their degree or type of processing.

查看原文本刊更多论文

超临界食品（UPF）、健康和机理的不确定性：我们应该建议公众如何对待超临界食品？

在这篇论文中，我们将讨论为什么目前在超临界食品（UPFs）与健康的机理方面存在不确定性，这对提供有关超临界食品的知情膳食指南和公众建议构成了重大挑战。根据目前的证据平衡，我们认为不宜建议消费者避免食用所有超临界食品，我们期待有更多证据为消费者提供指导，说明是否需要根据加工程度或类型限制食用特定食品。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PLoS Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

17.60

自引率

0.60%

发文量

227

审稿时长

4-8 weeks

期刊介绍： PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.